Skip to main content
SpringerLink
Log in

Bedford Laboratories has issued guidance on the voluntary recall of Polymyxin B for injection USP

  • Media release
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Bedford Laboratories.Bedford Laboratories Issues Guidance On 2011 Voluntary Recall Of Polymyxin B For Injection USP And Vecuronium Bromide For Injection Related To Glass Particles. Media Release: 10 Jan 2012. Available from: URL: http://www.fda.gov

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bedford Laboratories has issued guidance on the voluntary recall of Polymyxin B for injection USP. React. Wkly. 1385, 5 (2012). https://doi.org/10.2165/00128415-201213850-00009

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201213850-00009

Keywords

Search

Navigation